HLA-A2 phenotype may be protective against graves' disease but not against Hashimoto's thyroiditis in caucasians

Hormone and Metabolic Research

Volumn 45, Issue 1, 2013, Pages 74-77

  Bernecker, C ^a   Ostapczuk, M ^b   Vordenbaumen S ^a   Ehlers, M ^a   Thiel, A ^a   Schinner, S ^a   Willenberg, H ^a   Scherbaum, W A ^a   Schott, M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

autoimmune thyroiditis; autoimmunity; Graves' disease; Hashimoto's thyroiditis; major histocompatibility complex (MHC); thyroid epidemiology

Indexed keywords

HLA A2 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HLA-A2 ANTIGEN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK FACTORS; YOUNG ADULT;

EID: 84872309447     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1323704     Document Type: Article

References (42)

1. Ehlers M., Thiel A., Bernecker C., Porwol D., Papewalis C., Willenberg H. S., Schinner S., Hautzel H., Scherbaum W. A., Schott M. Evidence of a Combined Cytotoxic Thyroglobulin and Thyroperoxidase Epitope-Specific Cellular Immunity in Hashimotos Thyroiditis. J Clin Endocrinol Metab: 2012; 97 1347 1354
2. Pearce E. N., Farwell A. P., Braverman L. E. Thyroiditis. N Engl J Med: 2003; 2646 2655 (Pubitemid 36741593)
3. Aust G., Hofmann A., Laue S., Ode-Hakim S., Scherbaum W. A. Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-1 alpha and tumor necrosis factor-alpha. J Endocrinol: 1996; 151 277 285 (Pubitemid 26398006)
4. Jacobson E. M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun: 2007; 28 85 98 (Pubitemid 46670687)
5. Schott M., Minich W. B., Willenberg H. S., Papewalis C., Seissler J., Feldkamp J., Bergmann A., Scherbaum W. A., Morgenthaler N. G. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves disease. Horm Metab Res: 2005; 37 741 744 (Pubitemid 43028075)
6. Zöphe K., Roggenbuck D., von Landenberg P., Wunderlich G., Grüning T., Kotzerke J., Lackner K. J., Rees Smith B. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res: 2010; 42 65 69
7. Prummel M. F., Strieder T., Wiersinga W. M. The environment and autoimmune thyroid diseases. Eur J Endocrinol: 2004; 150 605 618 (Pubitemid 38786529)
8. Tomer Y., Davies T. F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev: 2003; 24 694 717 (Pubitemid 37330587)
9. Ban Y., Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol: 2005; 12 47 58 (Pubitemid 41647030)
10. Simmonds M. J., Gough SC L. Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol: 2004; 136 1 10 (Pubitemid 38437757)
11. Nelson J. L., Hansen J. A. Autoimmune diseases and HLA. Crit Rev Immunol: 1990; 10 307 328 (Pubitemid 20262633)
12. Yanagawa T., Mangklabruks A., Chang Y. B., Okamoto Y., Fisfalen M. E., Curran P. G., DeGroot L. J. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves disease in a Caucasian population. J Clin Endocrinol Metab: 1993; 76 1569 1574 (Pubitemid 23164379)
13. Marga M., Denisova A., Sochnev A., Pirags V., Farid N. R. Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet: 2001; 102 188 191 (Pubitemid 32674994)
14. Zamani M., Spaepen M., Bex M., Bouillon R., Cassiman J. J. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet: 2000; 95 432 437
15. Mangklabruks A., Cox N., DeGroot L. J. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab: 1991; 73 236 244 (Pubitemid 21921864)
16. Farid N. Graves disease. In: Farid N. R. (ed.). Hla in endocrine and metabolic disorders. New York Academic Press: 1981; 85 143
17. Stenszky V., Kozma L., Balázs C., Rochlitz S., Bear J. C., Farid N. R. The genetics of Graves disease: HLA and disease susceptibility. J Clin Endocrinol Metab: 1985; 61 735 740 (Pubitemid 16248100)
18. Gough SC L., Simmonds M. J. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomic: 2007; 8 453 465 (Pubitemid 351486276)
19. Tandon N., Zhang L., Weetman A. P. HLA associations with Hashimotos thyroiditis. Clin Endocrinol: 1991; 34 383 386
20. Petrone A., Giorgi A., Mesturino C. A., Capizzi M., Cascino I., Nistico L., Osborn J., Di Mario U., Buzzetti R. Association of DRB1*04- DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimotos thyroiditis in an Italian population. Thyroid: 2001; 11 171 175 (Pubitemid 32221042)
21. Inoue D., Sato K., Enomoto T., Sugawa H., Maeda M., Inoko H., Tsuji K., Mori T., Imura H. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves disease: evidence indicating the existence of four subpopulations. Clin Endocrinol: 1992; 36 75 82
22. Chan S. H., Lin Y. N., Wee G. B., Ren E. C., Lui K. F., Cheah J. S. Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves disease. Ann Acad Med Singap: 1993; 22 576 579
23. Brixner V., Mosebach M., Schmidt M., Hermann S., Seifried E., Martin H., Seidl C. HLA-DRB1*0826 and HLA-DQB1*0627, two novel class II alleles identified in blood stem cell donors of Caucasian origin. Tissue Antigens: 2006; 67 160 162 (Pubitemid 43383395)
24. Gonzalez-Galarza F. F., Christmas S., Middleton D., Jones A. R. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res: 2011; 39 913 919
25. Schott M., Hermsen D., Broecker-Preuss M., Casati M., Mas J. C., Eckstein A., Gassner D., Golla R., Graeber C., van Helden J., Inomata K., Jarausch J., Kratzsch J., Miyazaki N., Moreno MA N., Murakami T., Roth H. J., Stock W., Noh J. Y., Scherbaum W. A., Mann K. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves disease (GD): an international multicentre trial. Clin Endocrinol: 2009; 71 566 573
26. Herbert R. Confidence interval calculator. Sydney The George Institute for Global Health: 2011
27. Cohen J. Statistical power analysis for the behavioral sciences. Hove Lawrence Erlbaum Associates: 1988
28. Tomer Y., Davies T. F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev: 2003; 24 694 717 (Pubitemid 37330587)
29. Farid N. R., Sampson L., Moens H., Barnard J. M. The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens: 1981; 17 265 268 (Pubitemid 11157094)
30. Hanafusa T., Pujol-Borrell R., Chiovato L., Russell R. C., Doniach D., Bottazzo G. F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves disease: relevance for autoimmunity. Lancet: 1983; 2 1111 1115 (Pubitemid 14242393)
31. Dong R. P., Kimura A., Okubo R., Shinagawa H., Tamai H., Nishimura Y., Sasazuki T. HLA-A and DPB1 loci confer susceptibility to Graves disease. Hum Immunol: 1992; 35 165 172 (Pubitemid 23019551)
32. Kawa A. Nakamura Nakazawa M., Sakaguchi S., Kawabata T., Maeda Y., Kanehisa T. HLA-BW35 and B5 in Japanese patients with Graves disease. Acta Endocrinol: 1977; 86 754 757 (Pubitemid 8219810)
33. Onuma H., Ota M., Sugenoya A., Inoko H. Association of HLA-DPB1*0501 with early-onset Graves disease in Japanese. Hum Immunol: 1994; 39 195 201
34. Katsuren E., Awata T., Matsumoto C., Yamamoto K. HLA class II alleles in Japanese patients with Graves disease: weak associations of HLA-DR and -DQ. Endocr J: 1994; 41 599 603
35. Ohtsuka K., Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol: 1998; 126 805 810 (Pubitemid 29001630)
36. Hollowell J. G., Staehling N. W., Flanders W. D., Hannon W. H., Gunter E. W., Spencer C. A., Braverman L. E. Serum TSH T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab: 2002; 87 489 499 (Pubitemid 34158210)
37. Jacobson D. L., Gange S. J., Rose N. R., Graham N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol: 1997; 84 223 243 (Pubitemid 27398022)
38. Kasagi K., Takahashi N., Inoue G., Honda T., Kawachi Y., Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid: 2009; 19 937 944
39. Yamashita S., Amino N., Shong Y. K. The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea. Thyroid: 2011; 21 577 580
40. Jacobson E. M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun: 2008; 30 58 62
41. Davies T. F., Amino N. A new classification for human autoimmune thyroid disease. Thyroid: 1993; 3 331 333 (Pubitemid 24015330)
42. Yoshida H., Amino N., Yagawa K., Uemura K., Satoh M., Miyai K., Kumahara Y. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab: 1978; 46 859 862 (Pubitemid 8358346)